| |
|
|
|
|
|
|
|||
|
Blood, 1 June 2006, Vol. 107, No. 11, pp. 4201-4202.
PI-3K controls B cells' sweet toothUNIVERSITY OF FLORIDA
B cells need to meet specific energy demands of their rapid exponential growth. Doughty and colleagues show that B-cellreceptor engagement increases glucose metabolism through PI-3K signaling.
In contrast, the regulation of the metabolic requirements of B cells is largely unknown. Doughty and colleagues show that ligation of the B-cell receptor (BCR) results in 2 fundamental events: increase in glucose uptake by increasing the expression of the facilitated Glut1 transporter, and a rapid and sustained increase in glucose metabolism, which occurs prior to cell size growth and proliferation. This increase in glucose utilization is an absolute requirement for B-cell growth. In addition to glycolysis, BCR ligation also triggers glucose catabolism through the pentose phosphate pathway. The significance of this new finding is currently unclear. Of interest, all the energy requirements for B-cell growth were met by the sole BCR engagement in the absence of costimulation or growth factors, which are required in T cells. It will be of great interest to determine the metabolic response of B cells to CD40 ligation, IL-4, or LPS exposure, all of which have significant impact on B-cell growth and signaling. Doughty and colleagues demonstrate that, similarly to T cells, the phosphatidylinositol 3-kinase (PI-3K) plays an essential role in increased glucose utilization in BCR-stimulated B cells. Conditional expression of activated protein kinase B/AKT, a downstream target of PI-3K, is sufficient to increase glucose utilization in the absence of BCR engagement. It is very satisfying that the authors were able to show that coengagement of BCR and Fc
These new results should open the way to new studies on B-cell metabolism to determine how glucose utilization is altered not only by other stimulatory conditions, but also in the progression of B cells through peripheral development. The various B-cell subsets that have been described from transitional cells to plasma cells have very different functions in health and in disease and, one might speculate, different energy needs. A better understanding of these energy requirements and their regulation may allow targeting of specific B-cell subsets for amplification or reduction, according to therapeutic requirements. References
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||